Important Safety Information
SpeediCath® catheters are indicated for use by patients with chronic urine retention and patients with a post void residual volume (PVR) due to neurogenic and non-neurogenic voiding dysfunction. The catheter is inserted into the urethra to reach the bladder allowing urine to drain. There is a separate SpeediCath Compact and SpeediCath Compact Set device intended for either males or females only.
SpeediCath catheters are available by prescription only. Patients performing self-catheterization should follow the advice of, and direct questions about use of the product to, their medical professional. Before using the device, carefully read the product labels and information accompanying the device including the instructions for use which contain additional safety information. The SpeediCath catheter is for single-use only; discard it after use. If you experience symptoms of a urinary tract infection, or are unable to pass the catheter into the bladder, contact your healthcare professional. The risk information provided here is not comprehensive.
To learn more, talk to your healthcare provider. For further information, call Coloplast Corp at 1-866-226-6362 and/or consult the company website at www.coloplast.us.